Checkpoint inhibitor therapies have made metastatic melanoma and other cancers a survivable condition for 20 to 30 percent of treated patients, but clinicians have had very limited ways of knowing which patients will respond. Researchers have uncovered a novel mechanism by which tumors suppress the immune system. Their findings also usher in the possibility that a straightforward blood test could predict and monitor cancer patients' response to immunothera..
Viruses found to use intricate 'treadmill' to move cargo across bacterial cells: State-of-the-art technologies reveal bacterial cells organized like human cells, offering insights for new phage therapies on untreatable infections
Your works only be popular when others learn about your work.